The Affiliated Hospital of Qingdao University Phase I Clinical Research Center
Welcome,         Profile    Billing    Logout  
 11 Trials 
48 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Cao, Yu
NCT04624854: Dual Anti-Platelet Therapy in Patients With Coronary Multi-Vessel Disease (DAPT-MVD)

Active, not recruiting
4
8250
RoW
Clopidogrel and Aspirin dual-antiplatelet therapy, Aspirin monotherapy
Harbin Medical University, Chinese Society of Cardiology, Lepu Medical Technology (Beijing) Co., Ltd.
Coronary Artery Disease, Myocardial Ischemia, Acute Coronary Syndrome, Heart Diseases, Syndrome Heart Disease, Cardiovascular Diseases, Arteriosclerosis, Arterial Occlusive Diseases, Coronary Disease, Vascular Diseases
04/25
04/25
NCT06136507: Study of Efficacy and Safety of FRSW107 in Pediatric Patients With Severe Hemophilia A

Not yet recruiting
3
76
RoW
FRSW107, Recombinant Human Coagulation Factor Ⅷ，Fc Fusion Protein for Injection
Jiangsu Gensciences lnc.
Severe Hemophilia A
12/26
12/26
NCT03811015: Testing Immunotherapy Versus Observation in Patients With HPV Throat Cancer

Suspended
3
636
US
Biospecimen Collection, Biological Sample Collection, Biospecimen Collected, Specimen Collection, Cisplatin, Abiplatin, Blastolem, Briplatin, CDDP, Cis-diammine-dichloroplatinum, Cis-diamminedichloridoplatinum, Cis-diamminedichloro Platinum (II), Cis-diamminedichloroplatinum, Cis-dichloroammine Platinum (II), Cis-platinous Diamine Dichloride, Cis-platinum, Cis-platinum II, Cis-platinum II Diamine Dichloride, Cismaplat, Cisplatina, Cisplatinum, Cisplatyl, Citoplatino, Citosin, Cysplatyna, DDP, Lederplatin, Metaplatin, Neoplatin, Peyrone's Chloride, Peyrone's Salt, Placis, Plastistil, Platamine, Platiblastin, Platiblastin-S, Platinex, Platinol, Platinol- AQ, Platinol-AQ, Platinol-AQ VHA Plus, Platinoxan, Platinum, Platinum Diamminodichloride, Platiran, Platistin, Platosin, Computed Tomography, CAT, CAT Scan, Computed Axial Tomography, Computerized Axial Tomography, Computerized axial tomography (procedure), Computerized Tomography, Computerized Tomography (CT) scan, CT, CT Scan, tomography, Echocardiography, EC, Fludeoxyglucose F-18, 18FDG, FDG, Fludeoxyglucose (18F), fludeoxyglucose F 18, Fludeoxyglucose F18, Fluorine-18 2-Fluoro-2-deoxy-D-Glucose, Fluorodeoxyglucose F18, Intensity-Modulated Radiation Therapy, IMRT, Intensity modulated radiation therapy (procedure), Intensity Modulated RT, Intensity-Modulated Radiotherapy, Radiation, Intensity-Modulated Radiotherapy, Nivolumab, ABP 206, BCD-263, BMS 936558, BMS-936558, BMS936558, CMAB819, MDX 1106, MDX-1106, MDX1106, NIVO, Nivolumab Biosimilar ABP 206, Nivolumab Biosimilar BCD-263, Nivolumab Biosimilar CMAB819, ONO 4538, ONO-4538, ONO4538, Opdivo, Patient Observation, Active Surveillance, deferred therapy, expectant management, Observation, Watchful Waiting, Positron Emission Tomography, Medical Imaging, Positron Emission Tomography, PET, PET Scan, Positron emission tomography (procedure), Positron Emission Tomography Scan, Positron-Emission Tomography, proton magnetic resonance spectroscopic imaging, PT
National Cancer Institute (NCI)
Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Pathologic Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Pathologic Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
01/27
01/27
NRG-HN001, NCT02135042: Individualized Treatment in Treating Patients With Stage II-IVB Nasopharyngeal Cancer Based on EBV DNA

Active, not recruiting
2/3
685
Canada, US, RoW
Cisplatin, Abiplatin, Blastolem, Briplatin, CDDP, Cis-diammine-dichloroplatinum, Cis-diamminedichloridoplatinum, Cis-diamminedichloro Platinum (II), Cis-diamminedichloroplatinum, Cis-dichloroammine Platinum (II), Cis-platinous Diamine Dichloride, Cis-platinum, Cis-platinum II, Cis-platinum II Diamine Dichloride, Cismaplat, Cisplatina, Cisplatinum, Cisplatyl, Citoplatino, Citosin, Cysplatyna, DDP, Lederplatin, Metaplatin, Neoplatin, Peyrone's Chloride, Peyrone's Salt, Placis, Plastistil, Platamine, Platiblastin, Platiblastin-S, Platinex, Platinol, Platinol- AQ, Platinol-AQ, Platinol-AQ VHA Plus, Platinoxan, Platinum, Platinum Diamminodichloride, Platiran, Platistin, Platosin, Clinical Observation, Fluorouracil, 5-Fluoro-2,4(1H, 3H)-pyrimidinedione, 5-Fluorouracil, 5-Fluracil, 5-FU, AccuSite, Actino-Hermal, Adrucil, Arumel, Cytosafe, Efudex, Efurix, Fiverocil, Fluoro Uracil, Fluoroplex, Fluouracil, Flurablastin, Fluracedyl, Fluracil, Fluril, Fluroblastin, Flurox, Ribofluor, Ro 2-9757, Ro-2-9757, Timazin, Gemcitabine Hydrochloride, dFdCyd, Difluorodeoxycytidine Hydrochloride, Gemzar, LY-188011, Intensity-Modulated Radiation Therapy, IMRT, Intensity Modulated RT, Intensity-Modulated Radiotherapy, Laboratory Biomarker Analysis, Paclitaxel, Anzatax, Asotax, Bristaxol, Praxel, Taxol, Taxol Konzentrat, Quality-of-Life Assessment, Quality of Life Assessment
NRG Oncology, National Cancer Institute (NCI)
Epstein-Barr Virus Infection, Stage II Nasopharyngeal Carcinoma, Stage III Nasopharyngeal Carcinoma, Stage IVA Nasopharyngeal Carcinoma, Stage IVB Nasopharyngeal Carcinoma
02/26
02/31
NCT05265286: A Study of Repeat Dosing of PEG Recombinant Human Coagulation Factor VIII-Fc Fusion Protein for Injection

Completed
2
15
RoW
FRSW117, PEG Recombinant Human Coagulation Factor VIII-Fc Fusion Protein for Injection
Jiangsu Gensciences lnc.
Severe Hemophilia A
08/22
08/22
NCT04671667: Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma

Recruiting
2
188
US
Carboplatin, Blastocarb, Carboplat, Carboplatin Hexal, Carboplatino, Carboplatinum, Carbosin, Carbosol, Carbotec, CBDCA, Displata, Ercar, JM-8, JM8, Nealorin, Novoplatinum, Paraplatin, Paraplatin AQ, Paraplatine, Platinwas, Ribocarbo, Cisplatin, Abiplatin, Blastolem, Briplatin, CDDP, Cis-diammine-dichloroplatinum, Cis-diamminedichloridoplatinum, Cis-diamminedichloro Platinum (II), Cis-diamminedichloroplatinum, Cis-dichloroammine Platinum (II), Cis-platinous Diamine Dichloride, Cis-platinum, Cis-platinum II, Cis-platinum II Diamine Dichloride, Cismaplat, Cisplatina, Cisplatinum, Cisplatyl, Citoplatino, Citosin, Cysplatyna, DDP, Lederplatin, Metaplatin, Neoplatin, Peyrone's Chloride, Peyrone's Salt, Placis, Plastistil, Platamine, Platiblastin, Platiblastin-S, Platinex, Platinol, Platinol- AQ, Platinol-AQ, Platinol-AQ VHA Plus, Platinoxan, Platinum, Platinum Diamminodichloride, Platiran, Platistin, Platosin, Computed Tomography, CAT, CAT Scan, Computed Axial Tomography, Computerized Axial Tomography, Computerized axial tomography (procedure), Computerized Tomography, Computerized Tomography (CT) scan, CT, CT Scan, tomography, Intensity-Modulated Radiation Therapy, IMRT, Intensity modulated radiation therapy (procedure), Intensity Modulated RT, Intensity-Modulated Radiotherapy, Radiation, Intensity-Modulated Radiotherapy, Magnetic Resonance Imaging, Magnetic Resonance, Magnetic Resonance Imaging (MRI), Magnetic resonance imaging (procedure), Magnetic Resonance Imaging Scan, Medical Imaging, Magnetic Resonance / Nuclear Magnetic Resonance, MR, MR Imaging, MRI, MRI Scan, MRIs, NMR Imaging, NMRI, Nuclear Magnetic Resonance Imaging, sMRI, Structural MRI, Pembrolizumab, BCD-201, GME 751, GME751, Keytruda, Lambrolizumab, MK 3475, MK-3475, MK3475, Pembrolizumab Biosimilar BCD-201, Pembrolizumab Biosimilar GME751, Pembrolizumab Biosimilar QL2107, Pembrolizumab Biosimilar RPH-075, QL2107, RPH 075, RPH-075, RPH075, SCH 900475, SCH-900475, SCH900475, Proton Beam Radiation Therapy, External beam radiation therapy protons (procedure), External Beam Radiotherapy (protons), PBRT, Proton, Proton EBRT, Proton External Beam Radiotherapy, Proton Radiation Therapy, PROTON Therapy, Radiation, Proton Beam
National Cancer Institute (NCI)
Recurrent Head and Neck Squamous Cell Carcinoma, Recurrent Hypopharyngeal Squamous Cell Carcinoma, Recurrent Laryngeal Squamous Cell Carcinoma, Recurrent Oral Cavity Squamous Cell Carcinoma, Recurrent Oropharyngeal Squamous Cell Carcinoma
02/26
02/26
HATCH, NCT04691141: A Study to Evaluating the Pharmacokinetics, Safety, and Efficacy of ATG 016 Monotherapy in IPSS-R Intermediate Risk and Above Myelodysplastic Syndrome (MDS)

Terminated
1/2
15
RoW
ATG-016
Shanghai Antengene Corporation Limited
Myelodysplastic Syndrome
09/23
09/23
NCT05786339: Bioequivalence Study of Two Irbesartan in Healthy Chinese Subjects

Completed
1
68
RoW
Tested Irbesartan Tablet, Reference Irbesartan Tablet
The Affiliated Hospital of Qingdao University
Therapeutic Equivalency
01/19
05/19
NCT06021574: A First-in-human Study of a Novel Recombinant Humanized Anti-interleukin-6 Receptor Monoclonal Antibody

Completed
1
40
RoW
VDJ001, Placebo
The Affiliated Hospital of Qingdao University, Beijing VDJBio Co., LTD.
Healthy
01/20
01/20
NCT04438720: Bioequivalence of Extended Release Nifedipine Tablets in Healthy Chinese Subjects

Recruiting
1
60
RoW
Extended Release Nifedipine Tablets 30 mg, Extended Release Nifedipine Tablets 30 mg (Adalat® GITS)
Cao Yu
Therapeutic Equivalency
09/20
09/20
NCT04902534: Clinical Trial of Naoqingzhiming Tablets in Healthy Chinese Subjects

Recruiting
1
76
RoW
Naoqingzhiming Tablets (contains echinacoside 180mg), placebo of Naoqingzhiming Tablets (without echinacoside)
The Affiliated Hospital of Qingdao University
Healthy Volunteers
05/21
06/21
NCT04814589: Bioequivalence of Ezetimibe Tablets in Healthy Subjects

Recruiting
1
96
RoW
ezetimibe tablets, ezetimibe tablets(Ezetrol ®)
Cao Yu
Therapeutic Equivalency
06/21
07/21
NCT04951765: Effect of Food on the Pharmacokinetics of XZP-3287 in Healthy Subjects

Recruiting
1
24
RoW
XZP-3287
Xuanzhu Biopharmaceutical Co., Ltd.
Healthy
08/21
12/21
NCT05034120: Food Effect and Mass Balance Study of XZP-3621 Tablets

Not yet recruiting
1
34
RoW
XZP-3621
Xuanzhu Biopharmaceutical Co., Ltd.
Healthy
11/21
12/21
QL-YK1-045-001, NCT05168176: Bioequivalence of Dotilavir Sodium Tablets in Healthy Subjects in the Fasting and Fed State

Recruiting
1
64
RoW
Dotilavir sodium tablet, Dotilavir sodium tablet(Tivicay@)
The Affiliated Hospital of Qingdao University
Healthy Volunteers
12/21
01/22
CuminUP30, NCT05334043: Pharmacokinetics and Bioavailability of Curcumin UP 30 Capsules in Healthy Adult Subjects

Recruiting
1
12
RoW
CuminUP30, Curcumin capsules
The Affiliated Hospital of Qingdao University, Chenland Nutritionals Inc.
Healthy Adult Subjects
04/22
12/22
NCT05297929: A Bioequivalence Trial of Irbesartan Tablets（0.15g） in Healthy Chinese Subjects

Recruiting
1
54
RoW
Irbesartan Tablet
The Affiliated Hospital of Qingdao University
Irbesartan Tablets (0.15g/Tablet), Under Fasted Condition, Under Fed Condition, Bioequivalence
04/22
12/22
NCT05324423: To Evaluate Drug Interactions Between XNW3009, Febuxostat, and Colchicine in Patients With Gout

Recruiting
1
20
RoW
Colchicine, Febuxostat、XNW3009
The Affiliated Hospital of Qingdao University
Gout
08/22
09/22
NCT05381870: Bioequivalence Study of Ezetimibe Tablets Under Fasting Conditions in Healthy Subjects

Not yet recruiting
1
48
NA
Test Preparation-Reference preparation, Reference preparation-Test Preparation
The Affiliated Hospital of Qingdao University, Changzhou Pharmaceutical Factory Co., Ltd
Pharmacokinetics, Safety
08/22
12/22
NCT05226013: Tolerance, Pharmacokinetics / Pharmacodynamics (PK / PD) and Immunogenicity of Pegylated Uric Acid Oxidase for Injection in Healthy Adults and Hyperuricemia Volunteers

Recruiting
1
54
RoW
Polyglycol lated urate oxidase for injection, Placebo
The Affiliated Hospital of Qingdao University
Hyperuricemia
12/22
04/23
NCT05486598: A Study of Diet Influence of AL8326 in Chinese Healthy Adult Subjects

Recruiting
1
16
RoW
AL8326 tablets, AL8326
Advenchen Laboratories Nanjing Ltd.
Diet, High-Fat, Pharmacokinetics
12/22
12/22
NCT05398510: A Study to Evaluate the Safety, Tolerability and Pharmacokinetics Pharmacodynamics of SHR-2010 by Intravenously/Subcutaneously in Healthy Subject

Completed
1
61
RoW
SHR-2010 injection, SHR-2010 injection placebo
Guangdong Hengrui Pharmaceutical Co., Ltd
IgA Nephropathy
03/23
03/23
NCT05380934: A Clinical Trial of Safety and Tolerance of TQH3821 Tablets in Adult Healthy Subjects

Completed
1
63
RoW
TQH3821 tablets, TQH3821 tablets (Placebo), Methotrexate tablets
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Rheumatoid Arthritis
05/23
05/23
NCT05586568: Drug-drug Interaction Study of XZP-3621 Tablet

Not yet recruiting
1
72
RoW
XZP-3621 tablet and itraconazole oral liquid (for Arm1), XZP-3621 tablet and Rifampicin capsules (For Arm 2), XZP-3621 tablet and esomeprazole tablet (For Arm3)
Xuanzhu Biopharmaceutical Co., Ltd.
Healthy Subjects
04/23
08/23
NCT05505955: Study of HRS-5965 in Healthy Subjects and Subjects With Renal Insufficiency

Completed
1
83
RoW
HRS-5965, Placebo
Chengdu Suncadia Medicine Co., Ltd.
Glomerulonephritis
11/23
11/23
NCT05409326: A Study of TQH2722 Injection to Evaluate the Safety, Tolerability, Pharmacokinetics, Efficacy and Immunogenicity in Healthy Adult Subjects

Recruiting
1
48
RoW
TQH2722 injection, Placebo to match TQH2722
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.
Atopic Dermatitis
06/23
08/23
YY-BFNT-2023, NCT06589921: Comparative Pharmacokinetic Study of Pirfenidone Modified-Release Tablets and Pirfenidone Tablets in Healthy Subjects Under Fed Conditions

Completed
1
24
RoW
Pirfenidone Modified-Release Tablets, Pirfenidone Tablets
Overseas Pharmaceuticals, Ltd.
Idiopathic Pulmonary Fibrosis
09/23
09/23
NCT05984368: A Clinical Study of BG136 Injection in Healthy Chinese Volunteers

Recruiting
1
74
RoW
BG136, Placebo
The Affiliated Hospital of Qingdao University
Healthy
09/23
05/24
NCT05976737: Bioequivalence Study of Entacapone,Levodopa and Carbidopa Tablets in Healthy Chinese Subjects

Not yet recruiting
1
68
NA
Test (T) Entacapone,Levodopa and Carbidopa Tablets (II), Reference (R) Entacapone,Levodopa and Carbidopa Tablets (II)
The Affiliated Hospital of Qingdao University
Healthy
09/23
07/24
NCT06066112: Study on the Bioequivalence of Amisulpride Orally Disintegrating Tablets in Human Body

Recruiting
1
100
RoW
Drug: Test (T) Amisulpride orally disintegrating tablets (200mg). Produced and supplied by Zezheng (Shanghai) Biotechnology Co., Ltd., Reference (R) Amisulpride tablets (200mg). Produced and supplied by Zezheng (Shanghai) Biotechnology Co., Ltd.
The Affiliated Hospital of Qingdao University
Bioequivalence, Schizophrenia
10/23
03/24
TQB3454-I-03, NCT06139367: A Clinical Trial of TQB3454 Tablets in Healthy Adult Subjects

Not yet recruiting
1
40
RoW
TQB3454 tablets
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Biliary Carcinoma
12/23
12/23
NCT06126718: Phase I Randomized, Open-label, Parallel-controlled, Pharmacokinetic and Safety Study of BR201 Injection Versus Cosentyx in Healthy Male Subjects

Not yet recruiting
1
88
NA
BR201, Cosentyx（Secukinumab ）
BioRay Pharmaceutical Co., Ltd.
Psoriasis
06/24
08/24
NCT06521931: A Study of PN20 for the Prevention of Chemotherapy-induced Thrombocytopenia in Lymphoma or Solid Tumor Patients

Recruiting
1
24
RoW
PN20
Chongqing Peg-Bio Biopharm Co., Ltd.
Thrombocytopenia
12/24
12/24
NCT05942612: A Phase I Study of SHR -2001 in Healthy Subjects

Recruiting
1
49
RoW
SHR-2001, Placebo
Guangdong Hengrui Pharmaceutical Co., Ltd
Healthy
12/23
12/23
NCT06180720: Bioequivalence Study of Entacapone,Levodopa and Carbidopa Tablets in the Postprandial State in Healthy Chinese Subjects

Not yet recruiting
1
36
NA
Test (T) Entacapone,Levodopa and Carbidopa Tablets (II), Reference (R) Entacapone,Levodopa and Carbidopa Tablets (II)
The Affiliated Hospital of Qingdao University
Healthy
01/24
11/24
NCT06186414: A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of SIM0237 Alone or in Combination with BCG in NMIBC

Recruiting
1
152
RoW
SIM0237, SIM0237 and BCG
Jiangsu Simcere Pharmaceutical Co., Ltd., Shanghai Xianxiang Medical Technology Co., Ltd.
Non-Muscle-Invasive Bladder Cancer (NMIBC)
01/27
12/30
NCT06506175: Investigation of Optimal Dosage Regimen for HRS9531 Tablets in Healthy Subjects

Not yet recruiting
1
144
RoW
HRS9531 tablets
Fujian Shengdi Pharmaceutical Co., Ltd.
Overweight or Obese, Type 2 Diabetes
11/24
11/24
NCT06569381: Comparative Pharmacokinetic Study of Pirfenidone Modified-Release Tablets in Healthy Subjects Under Fasting and Fed Conditions

Not yet recruiting
1
18
RoW
Pirfenidone Modified-Release Tablets
Overseas Pharmaceuticals, Ltd., Shanghai ShouYan Clinical Development Co.,Ltd.
Idiopathic Pulmonary Fibrosis
09/24
12/24
NCT06022354: To Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SIM0278 in Chinese Healthy Subjects

Recruiting
1
84
RoW
SIM0278 Injection/Placebo
Jiangsu Simcere Pharmaceutical Co., Ltd.
Healthy Volunteers
05/25
07/25
NCT06683066: Study on Human Bioequivalence of Triprerelin Acetate for Injection

Recruiting
1
120
RoW
Triprorelin for injection, Diphereline
The Affiliated Hospital of Qingdao University, Shandong Cancer Hospital and Institute, Hunan Cancer Hospital, Shanxi Province Cancer Hospital, The First Affiliated Hospital of Shanxi Medical University, The Second Affiliated Hospital of Chongqing Medical University, First Affiliated Hospital of Chengdu Medical College, Zibo Central Hospital, Yuncheng Central Hospital, Yichang Central People's Hospital
Prostate Cancer (CRPC)
09/25
09/25
NCT06753864: A Single-center, Open, Randomized, Single-dose, Cross-over Bioequivalence Study to Evaluate the Effects of the Test Formulation Abalparatide Injection and the Reference Formulation Abalparatide Injection (Tymlos®) in Healthy Adult Subjects

Not yet recruiting
1
32
RoW
Test (T), Reference (R)
The Affiliated Hospital of Qingdao University
Osteoporosis
01/25
05/25
NCT05507489: Clinical Trial of Jinzhen Oral Liquid in Treating Children With COVID-19 Infection

Recruiting
N/A
240
RoW
Jinzhen oral liquid or Jinhuaqinggan granules
The Affiliated Hospital of Qingdao University
COVID-19, Child, Only
09/22
03/23
NCT06360965: Clinical Trial of Acupoint Application in Improving the Sequelae of Pelvic Inflammatory Disease and Chronic Pelvic Pain

Recruiting
N/A
102
RoW
Improved warm meridians and relieve pain plaster, Traditional warm meridians and relieve pain plaster, Placebo plaster
Beijing Hospital of Integrated Traditional Chinese and Western Medicine
Pelvic Inflammatory Disease, Chronic Pelvic Pain Syndrome
03/26
12/26
NCT06341283: A Retrospective Real-world Study of Abemaciclib in HR+ Breast Cancer

Not yet recruiting
N/A
200
RoW
Abemaciclib and Letrozole/Anastrozole, BCOOS-A1, Letrozole or Anastrozole, BCOOS-A2, Abemaciclib and Fulvestrant, BCOOS-B1, Fulvestrant, BCOOS-B2
The Affiliated Hospital of Qingdao University
Breast Cancer, Neoplasms, Breast Diseases
12/24
07/25
NCT05952375: Exploratory Clinical Trial on the Safety, Efficacy, and Pharmacokinetics of XKDCT086 (iPD-1-Claudin18.2-CAR-T) in Claudin 18.2 Positive Advanced Solid Malignant Tumors: a Single Center, Single Arm, Dose-increasing Trial

Recruiting
N/A
9
RoW
Chimeric antigen receptor T cell preparation targeting Claudin18.2
The Affiliated Hospital of Qingdao University
Gastric Cancer
02/25
02/25
NCT04212494: Thrombus Aspiration in STEMI Patients With High Thrombus Burden

Recruiting
N/A
3838
RoW
Thrombus aspiration, PCI Alone
Guangdong Provincial People's Hospital, Zhongshan People's Hospital, Guangdong, China, Kaiping Central Hospital, The Second Affiliated Hospital of Shantou University Medical College, The Third Xiangya Hospital of Central South University, Sihui City People's Hospital, Shenzhen Baoan District Shiyan People's Hospital, People's Hospital of Nanxiong County, Yuebei People's Hospital, Weifang Medical University, Wuzhou Gongren Hospital, Dafeng Hospital of Chaoyang District in Shantou City, Shenzhen Baoan People's Hospital, Dongguan People's Hospital, Yangchun People's Hospital, Taishan People's Hospital, The Second People's Hospital of Foshan, Guangzhou Hospital of integrated Traditional and West Medicine, Guangning People's Hospital, Foshan Sanshui District People's Hospital, Qingyuan People's Hospital, Luhe County People's Hospital, People's Hospital of Xinjiang Uygur Autonomous Region, The Fourth People's Hospital of Chenzhou, People's Hospital of Dapu County, Shenzhen People's Hospital, Heyuan people's Hospital, Huaiji People's Hospital, People's Hospital of Yingde City, Qingyuan Hospital of Traditional Chinese Medicine Affiliated To Guangzhou University of Traditional Chinese Medicine, Zhongshan Hospital Of Traditional Chinese Medicine, The Third Affiliated Hospital of Guangzhou Medical University, Lianzhou People's Hospital, Lianping Xian Ren Ming Yi Yuan, Guangxi Zhuang Autonomous Region Nationalities Hospital, Liuzhou Municipal Liutie Central Hospital, Chen Zhou 3RD People's Hospital, Longgang District Central Hospital of Shenzhen, The Affiliated Shunde Hospital of Jinan University, Shenzhen Longhua District Central Hospital, Shantou Central Hospital, Tongxiang First People's Hospital, Bobai County People's Hospital, Guangxi, Meizhou Traditional Chinese Medicine Hospital, The Third Affiliated Hospital of Sun Yat-Sen University, Yuedong Hospital, Shenzhen Third People's Hospital, Yangjiang People's Hospital, Jiangmen Central Hospital, Eighth Affiliated Hospital, Sun Yat-sen University, The First People's Hospital of Kashgar Erea, First People's Hospital of Foshan, Zhaoqing Gaoyao People's Hospital, People's Hospital of Nanhai District, Foshan, The Second Affiliated Hospital of Dalian Medical University, Nanning Second People's Hospital, The Second People's Hospital of Nanhai District of Foshan, Shangyou People's Hospital
ST-segment Elevation Myocardial Infarction (STEMI)
08/25
02/26
NCT06062524: Guo's False Lumen Embolization : The First in Man Study of WeFlow-EndoSeal Aorta Vascular Plug System

Recruiting
N/A
20
RoW
Aorta Vascular Plug System
Hangzhou Endonom Medtech Co., Ltd.
Aortic Dissection Aneurysm
05/26
05/26
NCT05088161: Prognostic Biomarkers of Pancreatic Cancer Based on Proteomics Techniques

Recruiting
N/A
20
RoW
The Affiliated Hospital of Qingdao University
Patients
11/21
03/22

Download Options